Literature DB >> 16765302

Antibiotics in childhood pneumonia.

Katherine A Hale1, David Isaacs.   

Abstract

Pneumonia is one of the most common global childhood illnesses. The diagnosis relies on a combination of clinical judgement and radiological and laboratory investigations. Streptococcus pneumoniae remains the most important cause of childhood community-acquired pneumonia. In addition, viruses (including respiratory syncytial virus) and atypical bacteria (Mycoplasma and Chlamydia) are likely pathogens in younger and older children in developed countries. In the minority of cases only, the actual organism is isolated to guide treatment. Antibiotics effective against the expected bacterial pathogens should be instituted where necessary. The route and duration of antibiotic therapy, the role of emerging pathogens and the impact of pneumococcal resistance and conjugate pneumococcal vaccines are also discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16765302     DOI: 10.1016/j.prrv.2006.03.011

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN: 1526-0542            Impact factor:   2.726


  7 in total

Review 1.  Airway clearance techniques to treat acute respiratory disorders in previously healthy children: where is the evidence?

Authors:  Kris De Boeck; François Vermeulen; Myriam Vreys; Marleen Moens; Marijke Proesmans
Journal:  Eur J Pediatr       Date:  2008-03-06       Impact factor: 3.183

2.  Assessment of Treatment of Community Acquired Severe Pneumonia by Two Different Antibiotics.

Authors:  Karimeldin Ma Salih; Jalal Ali Bilal; Widad Eldouch; Ali Abdin
Journal:  J Clin Diagn Res       Date:  2016-05-01

3.  Outcome of children hospitalized with community-acquired pneumonia treated with aqueous penicillin G.

Authors:  Raquel Simbalista; Marcelo Araújo; Cristiana M Nascimento-Carvalho
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

4.  The crystal structure of alanine racemase from Streptococcus pneumoniae, a target for structure-based drug design.

Authors:  Hookang Im; Miriam L Sharpe; Ulrich Strych; Milya Davlieva; Kurt L Krause
Journal:  BMC Microbiol       Date:  2011-05-25       Impact factor: 3.605

5.  Purification and preliminary crystallization of alanine racemase from Streptococcus pneumoniae.

Authors:  Ulrich Strych; Milya Davlieva; Joseph P Longtin; Eileen L Murphy; Hookang Im; Michael J Benedik; Kurt L Krause
Journal:  BMC Microbiol       Date:  2007-05-17       Impact factor: 3.605

6.  Scientific rationale for study design of community-based simplified antibiotic therapy trials in newborns and young infants with clinically diagnosed severe infections or fast breathing in South Asia and sub-Saharan Africa.

Authors:  Anita K M Zaidi; Abdullah H Baqui; Shamim Ahmad Qazi; Rajiv Bahl; Samir Saha; Adejumoke I Ayede; Ebunoluwa A Adejuyigbe; Cyril Engmann; Fabian Esamai; Antoinette Kitoto Tshefu; Robinson D Wammanda; Adegoke G Falade; Adetanwa Odebiyi; Peter Gisore; Adrien Lokangaka Longombe; William N Ogala; Shiyam Sundar Tikmani; A S M Nawshad Uddin Ahmed; Steve Wall; Neal Brandes; Daniel E Roth; Gary L Darmstadt
Journal:  Pediatr Infect Dis J       Date:  2013-09       Impact factor: 2.129

7.  Simplified antibiotic regimens for the management of clinically diagnosed severe infections in newborns and young infants in first-level facilities in Karachi, Pakistan: study design for an outpatient randomized controlled equivalence trial.

Authors:  Anita K M Zaidi; Shiyam Sundar Tikmani; Shazia Sultana; Benazir Baloch; Momin Kazi; Hamidur Rehman; Khairunnissa Karimi; Fyezah Jehan; Imran Ahmed; Simon Cousens
Journal:  Pediatr Infect Dis J       Date:  2013-09       Impact factor: 2.129

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.